Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.67 |
| ▸ | ADAM17 | P78536 | 6/20 | 0.67 |
| ▸ | MMP13 | P45452 | 2/20 | 0.67 |
| ▸ | MMP14 | P50281 | 2/20 | 0.67 |
| ▸ | MMP9 | P14780 | 10/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.58 |
| ▸ | MMP7 | P09237 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7302324 | 1.00 | MMP2 (0.67) | MMP2ADAM17MMP13MMP14MMP9 | |
| SCHEMBL7290422 | 0.89 | MMP9 (0.77) | MMP2ADAM17MMP9MEN1KMT2A | |
| SCHEMBL7290418 | 0.89 | MMP9 (0.77) | MMP2ADAM17MMP9MEN1KMT2A | |
| SCHEMBL7300467 | 0.86 | MMP9 (0.75) | MMP2ADAM17MMP9MEN1KMT2A | |
| SCHEMBL8428419 | 0.84 | ADAM17 (0.79) | MMP2ADAM17MMP13MMP14MMP9 | |
| SCHEMBL3154749 | 0.83 | MMP9 (0.88) | MMP2ADAM17MMP9MEN1KMT2A | |
| SCHEMBL3154764 | 0.83 | MMP9 (0.88) | MMP2ADAM17MMP9MEN1KMT2A | |
| SCHEMBL7291364 | 0.82 | MMP9 (0.72) | MMP2ADAM17MMP9MEN1KMT2A | |
| SCHEMBL23752240 | 0.80 | ADAM17 (1.00) | MMP2ADAM17MMP13MMP14MMP9 | |
| SCHEMBL3848822 | 0.80 | ADAM17 (1.00) | MMP2ADAM17MMP13MMP14MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5763436-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1998-06-09 | — | — | US | disclosed |
| US-5595999-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1997-01-21 | — | — | US | disclosed |
| US-5583133-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1996-12-10 | — | — | US | disclosed |
| US-5532232-A | INHIBIT THROMBIN INDUCED PLATELET AGGREGATION; FIBRINOGEN ANTICOAGULANTS IN BLOOD | HOFFMANN-LA ROCHE INC. (US) | 1996-07-02 | — | — | US | disclosed |
| US-5393760-A | Cardiovascular disorders, antitumor agents | HOFFMANN-LA ROCHE INC. (US) | 1995-02-28 | — | — | US | disclosed |
| EP-0468231-B1 | Guanidins | HOFFMANN LA ROCHE (CH) | 1994-09-21 | — | — | EP | disclosed |
| US-5260307-A | Inhibit thrombin-induced platlet aggregation and clotting of fibrogen in plasma | HOFMANN-LA ROCHE INC. (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0468231-A2 | Guanidins | F. HOFFMANN-LA ROCHE AG (CH) | 1992-01-29 | — | — | EP | disclosed |